TokenPost·
Gyre Therapeutics Posts $32.9 Million in Q3 Revenue, $0.04 GAAP Loss Per Share
Revenue rose 0.6% year over year, and the company maintained its 2026 revenue guidance at $100.5 million to $111 million.
More news
- TokenPostMitsubishi Heavy Industries Raises FY2026 Revenue Outlook to ¥6 Trillion
- TokenPostMichigan Senator-Elect El-Sayed Calls for AI Pause, Data Center Limits
- TokenPostDGB Gains 10.53% in Five Minutes, Reaching $0.00357 Saturday
- TokenPostHeritage Global Posts $14.6 Million in Q3 Revenue, $0.03 EPS
- TokenPostAnsem Says Micron's 34% Weekly Selloff Appeared Excessive
- TokenPostWestrock Coffee Company Q3 Sales Fall 15.4% to $300.2 Million